An imaging agent just approved by the FDA will allow surgeons to identify additional cancerous lesions, which otherwise would have been left behind, in up to 24% more patients during non-small cell lung cancer surgery. Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, is an inventor of the foundational intellectual property upon which the drug is based.
News | Lung Imaging
Imaging Agent Illuminates Lung Cancer Tumors

December 21, 2022 — Surgery, especially surgery to remove cancerous tumors, relies on a range of tools and techniques as ...

Time December 21, 2022
Home
ASTRO's statement stresses that it is deeply disappointed in radiation oncology cuts and fears for stability of community-based cancer clinics
News | ASTRO
ASTRO Issues Statement in Response to 2023 Omnibus Appropriations Bill

December 20, 2022 — The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board ...

Time December 20, 2022
Home
Company to expand robust Enterprise Imaging offering with addition of Inspirata’s Digital Pathology technology and team
News | Digital Pathology
Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to acquire the company’s Digital Pathology Business

December 20, 2022 — Fujifilm Corporation's President and CEO, Representative Director: Teiichi Goto, announced the ...

Time December 20, 2022
Home
Initiative Addresses Structural and Cultural Barriers to High-quality, Culturally Competent Health Care for Black and Hispanic Women; Delivers Innovative Health Research, Education and Access Model
News | Mammography
Hologic and Partners Launch Project Health Equality to Help Transform the Care Women of Color Receive in the Health Care System

December 20, 2022 — Hologic, Inc. launched Project Health Equality (PHE), a unique initiative that strives to address ...

Time December 20, 2022
Home
Travel Time for Breast Cancer Screening Remains Long for Many Women in the U.S., New Study Shows. Credit: American Cancer Society
News | Mammography
Travel Time for Breast Cancer Screening Remains Long for Many Women in the U.S., New Study Shows

December 19, 2022 — A new study led by researchers at the American Cancer Society (ACS) shows travel time to the nearest ...

Time December 19, 2022
Home
Researchers reveal new noninvasive MRI measures of the glymphatic system function that could be used to track Alzheimer disease progression
News | Magnetic Resonance Imaging (MRI)
Impaired Glymphatic System May be Linked with Progression of Alzheimer's Disease, Finds New Study

December 19, 2022 — The glymphatic system is the waste clearing pathway of the human brain. It is speculated that an ...

Time December 19, 2022
Home
Dr. Bernard King will be formally recognized as the 2023 ARRS Gold Medalist during the opening ceremony of the ARRS Annual Meeting in Honolulu, HI on Sunday, April 16, 2023.
News | ARRS
American Roentgen Ray Society Awards 2023 Gold Medal to Former ARRS President, Bernard F. King

December 19, 2022 — The American Roentgen Ray Society (ARRS) announced that Bernard F. King, Jr., MD, FACR, FSAR, the ...

Time December 19, 2022
Home
The devices contribute to advanced X-ray control and image generation with reduced noise using AI
News | Digital Radiography (DR)
Canon Announced New High-end Series of Wireless Digital Radiography Devices

December 19, 2022 — Canon Inc. announced the launch in July, in markets outside of Japan1, of the CXDI-Elite series of ...

Time December 19, 2022
Home
Murray Rebner, MD, FACR, FSBI
News | Society of Breast Imaging (SBI)
2023 SBI Gold Medal Award Winner: Dr. Murray Rebner

December 16, 2022 — Murray Rebner, MD, FACR, FSBI, has been named 2023 Gold Medal Award winner. He will be honored at ...

Time December 16, 2022
Home
New Ultrasound Compact System 5000 Series delivers premium image quality needed to aid in a confident diagnosis in a portable unit
News | Ultrasound Imaging
Philips Launches New Compact Ultrasound System at RSNA 2022, Allowing First-Time-Right Diagnosis for More Patients

December 16, 2022 — Royal Philips announced the global launch of a next-generation compact portable ultrasound solution ...

Time December 16, 2022
Home
#RSNA22 to be debut of GE Healthcare’s One-Stop Clinic Experience for Breast– an immersive experience for healthcare providers that presents our value-based breast care offering featuring a portfolio of solutions to advance women’s health and breast cancer care
News | Breast Imaging
GE Healthcare's Comprehensive Approach to Breast Cancer Care Addresses Key Challenges and Helps Advance a "Brighter" Future for Patients and Providers

December 16, 2022 — One in eight women develop breast cancer in their lifetime. 1 Regular screening mammograms can help ...

Time December 16, 2022
Home
New Ultrasound Compact System 5000 Series delivers premium image quality needed to aid in a confident diagnosis in a portable unit
News | Ultrasound Imaging
Philips Launches New Compact Ultrasound System at RSNA 2022

December 15, 2022 — Royal Philips announced the global launch of a next-generation compact portable ultrasound solution ...

Time December 15, 2022
Home
61-year-old male, post lung transplant, who underwent photon-counting detector CT of chest in ultra-high-resolution mode. Reconstructions were performed at 0.2-mm slice thickness with BI56 kernel (A), BI60 kernel (B), and BI64 kernel (C); at 0.4-mm slice thickness with BI56 kernel (D), BI60 kernel (E), and BI64 kernel (F); and at 1.0-mm slice thickness with BI56 kernel (G), BI60 kernel (H), and BI64 kernel (I). Clinical-reference reconstruction (BI64 kernel at 1.0-mm slice thickness) is shown with red outli
News | Computed Tomography (CT)
Kernel and Slice in Ultra-High-Resolution Photon-Counting Detector CT

December 15, 2022 — An accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR) guides ...

Time December 15, 2022
Home
Left to right: Tom Shields, CEO Shields Health; Dr. Christopher Filippi, Radiologist-in-Chief, Tufts Medical Center; Mike Foley, Executive Director of Radiology, Physical and Occupational Therapy, Tufts Medical Center; Dr. Michael Tarnoff, CEO, Tufts Medical Center; Diana Richardson, President, Tufts Medical Center; Peter Ferrari, President, Shields Health; Dianne Tripp, VP of Imaging, Shields Health; John Antaya, Chief Marketing Officer, Shields Health
News | Magnetic Resonance Imaging (MRI)
Shields Health and Tufts Medical Center Celebrate New 3T MRI Machine Designed to Improve Comfort and Quality

December 15, 2022 — Shields Health, New England’s largest network of independent imaging centers, and Tufts Medical ...

Time December 15, 2022
Home
Deciphex, a provider of pathology software and services, has announced the launch of it Digital Research Pathology Platform, Patholytix 3.0.
News | Digital Pathology
Deciphex Launches New Platform for Digital Pathology Review and Scoring

December 15, 2022 — Deciphex, a provider of pathology software and services, has announced the launch of it Digital ...

Time December 15, 2022
Home
RSNA22 kicked off on Nov. 27, welcoming attendees and exhibitors back to normalcy following the COVID-19 pandemic. This year's conference featured five days of educational programs for radiologists, radiation oncologists, medical physicists, radiologic technologists and allied healthcare professionals. You can read more about opening day here.
Gallery | RSNA | By Melinda Taschetta-Millane and Christine Book
Photo Gallery of Radiology Technology, Highlights from RSNA 2022

This gallery includes photos of the wide range of medical imaging technologies, scientific sessions, educational courses ...

Time December 15, 2022
Home
News | Radiology Imaging
Fujifilm Unveiled New Medical Imaging Advances at the RSNA 2022 Conference

December 15, 2022 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time December 15, 2022
Home
Mark Burgess, President North America Agfa HealthCare
News | Radiology Business
Mark Burgess Named President North America, Agfa HealthCare

December 15, 2022 — Agfa HealthCare announced Mark Burgess as President North America Agfa HealthCare, effective October ...

Time December 15, 2022
Home
data showed that CytoSite’s Granzyme B (GzmB) PET imaging using [68Ga-NOTA]-hGZP (CSB-111) was feasible and safe in human subjects. These data come from a Phase I trial assessing the safety and feasibility of GzmB PET imaging in subjects with melanoma and non-small cell lung cancer (NSCLC) receiving KEYTRUDA (pembrolizumab).
News | Flat Panel Displays
LG Innovations Previewed at RSNA 2022

December 14, 2022 — Previewing forward-looking solutions for healthcare providers and medical professionals, LG Business ...

Time December 14, 2022
Home
data showed that CytoSite’s Granzyme B (GzmB) PET imaging using [68Ga-NOTA]-hGZP (CSB-111) was feasible and safe in human subjects. These data come from a Phase I trial assessing the safety and feasibility of GzmB PET imaging in subjects with melanoma and non-small cell lung cancer (NSCLC) receiving KEYTRUDA (pembrolizumab).
News | Clinical Trials
CytoSite Bio Presents First-in-Human Data at Radiological Society of North American Annual Meeting

December 14, 2022 — CytoSite Bio, a company developing precision imaging products that determine patient response to ...

Time December 14, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now